Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation.
Tutschka
P J
PJ
Ohio State University, Division of Bone Marrow Transplantation, Columbus 43210.
Copelan
E A
EA
Kapoor
N
N
D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000601:surgery*; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control; D011292:Premedication; D014916:Whole-Body Irradiation
D002066:Busulfan